Back to Search
Start Over
Phase 1/2 study of weekly nab-paclitaxel (nab-P) in pediatric patients (pts) with recurrent/refractory solid tumors (STs): Dose-finding and pharmacokinetics (PK)
- Source :
- Journal of Clinical Oncology. 34:10551-10551
- Publication Year :
- 2016
- Publisher :
- American Society of Clinical Oncology (ASCO), 2016.
-
Abstract
- 10551Background: Although solvent-based paclitaxel has demonstrated activity in adult pts with STs, solvents produce significant neurotoxicity in pediatric pts. nab-P is an albumin–bound paclitaxel...
- Subjects :
- Cancer Research
business.industry
Neurotoxicity
macromolecular substances
Pharmacology
medicine.disease
carbohydrates (lipids)
stomatognathic diseases
03 medical and health sciences
Dose finding
chemistry.chemical_compound
0302 clinical medicine
Oncology
Refractory
Pharmacokinetics
Paclitaxel
chemistry
030225 pediatrics
030220 oncology & carcinogenesis
otorhinolaryngologic diseases
medicine
bacteria
business
Nab-paclitaxel
Subjects
Details
- ISSN :
- 15277755 and 0732183X
- Volume :
- 34
- Database :
- OpenAIRE
- Journal :
- Journal of Clinical Oncology
- Accession number :
- edsair.doi...........3a1802838912b37f652b9bccd2192c96